Anand G Patel1, Scott H Kaufmann. Show Affiliations » 1. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
Abstract
Entities: Disease
Mesh: See more » AnimalsAntineoplastic Agents, Phytogenic/administration & dosageAntineoplastic Agents, Phytogenic/metabolismAntineoplastic Agents, Phytogenic/toxicityBacteria/drug effectsBacteria/enzymologyCamptothecin/administration & dosageCamptothecin/analogs & derivativesCamptothecin/metabolismCamptothecin/toxicityDrug Evaluation, PreclinicalEnzyme Inhibitors/pharmacologyEscherichia coli/drug effectsEscherichia coli/enzymologyGlucuronidase/antagonists & inhibitorsIntestinal Mucosa/drug effectsIntestinal Mucosa/metabolismIntestinal Mucosa/microbiologyIrinotecanMice
Substances: See more » Antineoplastic Agents, PhytogenicEnzyme InhibitorsSN38-GluIrinotecanGlucuronidaseCamptothecin
Year: 2010 PMID: 21051622 DOI: 10.1126/science.1198310
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728